GAMMA Investing’s Opus Genetics IRD Stock Holding History

GAMMA Investing’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.08K	Buy	+636	New	+$2.64K	﹤0.01%	3828

Other funds holding IRD

Miller Financial Services Marshall, Michigan $132M AUM 10.64% 1-Year Est. Return

Empirical Wealth Management Seattle, Washington $7.38B AUM 22.9% 1-Year Est. Return

James Investment Research Alpha, Ohio $936M AUM 24.49% 1-Year Est. Return

Sanders Morris Harris Houston, Texas $755M AUM 11.28% 1-Year Est. Return

First City Capital Management Savannah, Georgia $204M AUM 20.28% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

Hilton Head Capital Partners Hilton Head Island, South Carolina $185M AUM 26.97% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

GAMMA Investing's IRD Position: Q3 2026 in Review

GAMMA Investing opened a new position in Opus Genetics (IRD) in Q3 2026: 636 shares worth $3.08K. The stake represents ﹤0.01% of the portfolio and ranks #3828 among its holdings.

14 funds tracked by Wall St. Rank hold IRD as of Q3 2026.

GAMMA Investing held 636 shares of Opus Genetics worth $3.08K as of Q3 2026.
Opus Genetics was a new GAMMA Investing position in Q3 2026.
Opus Genetics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3828 holding.
14 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.